| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/2011 | WO2011144742A1 Novel pyrimidine derivatives |
| 11/24/2011 | WO2011144727A1 Preparations of biologically active substances with enlarged surface area based on amphiphilic copolymers |
| 11/24/2011 | WO2011144725A2 Novel methods for preventing or treating diabetes |
| 11/24/2011 | WO2011144724A1 A pharmaceutical controlled release composition of losartan |
| 11/24/2011 | WO2011144721A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 11/24/2011 | WO2011144677A1 Pharmaceutical composition of ibuprofen for injection |
| 11/24/2011 | WO2011144673A2 Long - acting formulations of insulins |
| 11/24/2011 | WO2011144666A1 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 11/24/2011 | WO2011144655A1 Process for the preparation of chiral hydrazides |
| 11/24/2011 | WO2011144653A1 Process for the preparation of chiral triazolones |
| 11/24/2011 | WO2011144650A1 Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant |
| 11/24/2011 | WO2011144622A1 1h - imidazo [4, 5 - c] quinolines |
| 11/24/2011 | WO2011144585A1 Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors |
| 11/24/2011 | WO2011144584A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 11/24/2011 | WO2011144578A1 Compounds |
| 11/24/2011 | WO2011144577A1 Compounds |
| 11/24/2011 | WO2011144545A1 Theobromine for increasing hdl-cholesterol |
| 11/24/2011 | WO2011144501A1 Ccr2 antagonists and uses thereof |
| 11/24/2011 | WO2011144439A1 Compositions for the treatment of gynaecological disorders |
| 11/24/2011 | WO2011144358A1 Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof |
| 11/24/2011 | WO2011144338A1 Pyrazole derivatives as s1p1 agonists |
| 11/24/2011 | WO2011144335A1 Stable ready to use injectable paracetamol formulation |
| 11/24/2011 | WO2011144327A1 Posology and administration of glucocorticoid based compositions |
| 11/24/2011 | WO2011144248A1 Composition for removing atheromatous plaque |
| 11/24/2011 | WO2011144059A1 Fused quinazoline derivatives and uses thereof |
| 11/24/2011 | WO2011144054A1 Dibenzocyclooctene lignan derivatives and uses thereof in treatment of viral hepatitis |
| 11/24/2011 | WO2011144021A1 Cefpiramide sodium hydrate, preparation method and uses thereof |
| 11/24/2011 | WO2011144020A1 Indenoquinolone compound, preparation method and use thereof |
| 11/24/2011 | WO2011143935A1 Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof |
| 11/24/2011 | WO2011143932A1 Aromatic butan-2-ol compounds, preparation methods and uses thereof |
| 11/24/2011 | WO2011143927A1 Use of 2,3-dihydro-3-hydroxymethyl-6-amino-1,4-benzoxazine in preparing medicaments for inducing embryonic stem cells to differentiate into vascular endothelial cells |
| 11/24/2011 | WO2011143872A1 Crystal form of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparation method and use thereof |
| 11/24/2011 | WO2011143864A1 Anticancer compounds and preparation methods thereof |
| 11/24/2011 | WO2011143843A1 Atomizing formulation comprising plant extract and its preparation method |
| 11/24/2011 | WO2011143772A1 Inhibitors of hiv replication |
| 11/24/2011 | WO2011143762A1 Method for reducing expression of downregulated iν renal cell carcinoma iν malignant gliomas |
| 11/24/2011 | WO2011143752A1 Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal |
| 11/24/2011 | WO2011143721A1 Compositions and methods for treating neurodegenerative disorders |
| 11/24/2011 | WO2011121305A3 Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| 11/24/2011 | WO2011110683A3 Glce as a target for anti-tumour therapy |
| 11/24/2011 | WO2011110671A3 Pharmaceutical composition for the treatment of chlamydial infection |
| 11/24/2011 | WO2011109356A3 Anti-coagulant infusion fluid source |
| 11/24/2011 | WO2011106378A3 Oral b12 therapy |
| 11/24/2011 | WO2011100698A3 Methods of treating viral infection |
| 11/24/2011 | WO2011100668A4 Methods and compositions of civamide to treat diseases of the intestines |
| 11/24/2011 | WO2011091410A8 Trpv4 antagonists |
| 11/24/2011 | WO2011090738A3 Type ii raf kinase inhibitors |
| 11/24/2011 | WO2011088333A3 Solid-forming local anesthetic formulations for pain control |
| 11/24/2011 | WO2011087755A3 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| 11/24/2011 | WO2011087494A3 Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses |
| 11/24/2011 | WO2011085155A3 Formulations and methods for dissolving cerumen |
| 11/24/2011 | WO2011084513A3 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| 11/24/2011 | WO2011082267A3 Substituted triazolo-pyrazine compounds |
| 11/24/2011 | WO2011080651A3 Polymorphic forms of febuxostat |
| 11/24/2011 | WO2011079193A3 Preparation of bendamustine and its salts |
| 11/24/2011 | WO2011079142A3 Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
| 11/24/2011 | WO2011076841A3 Combination therapy for copd |
| 11/24/2011 | WO2011075539A3 Treatment of obesity or diabetes with bile acid sequestrants |
| 11/24/2011 | WO2011068703A3 Methods of modulating inflammation in preterm infants using carotenoids |
| 11/24/2011 | WO2011053792A4 Methods and compositions for sustained delivery of drugs |
| 11/24/2011 | WO2011052950A3 Pharmaceutical composition comprising indole compound |
| 11/24/2011 | WO2011050000A3 Single molecule nucleic acid nanoparticles |
| 11/24/2011 | WO2011039780A3 Topical formulation for diabetic foot ulcers |
| 11/24/2011 | WO2011038385A9 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 11/24/2011 | WO2011038097A3 Indolizine inhibitors of 5-lipoxygenase |
| 11/24/2011 | WO2011036558A3 Crystalline methylthionium chloride (methylene blue) hydrates |
| 11/24/2011 | WO2011036159A3 Treatment and prevention of hiv infection |
| 11/24/2011 | WO2011029088A3 Preparation of raloxifene and its salts |
| 11/24/2011 | WO2011018185A3 Pharmaceutical tablet comprising rosuvastatin calcium |
| 11/24/2011 | WO2011006611A3 Pellets formulation |
| 11/24/2011 | WO2010142400A3 Chitosan oligosaccharide-based compositions |
| 11/24/2011 | WO2010134047A3 Liquid dosage forms of isotretinoin |
| 11/24/2011 | WO2010129839A8 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans |
| 11/24/2011 | WO2010127856A8 Substituted phenylureas and phenylamides as vanilloid receptor ligands |
| 11/24/2011 | WO2010126173A3 Antiviral fiber assembly with cellulose sulfate |
| 11/24/2011 | WO2010097576A8 1, 4-disubstituted piperidines as vasopressin receptor via antagonists |
| 11/24/2011 | WO2010052466A8 Pharmaceutical aerosol composition |
| 11/24/2011 | WO2010017154A3 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 11/24/2011 | WO2009023160A8 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 11/24/2011 | US20110289611 Rna sequence-specific mediators of rna interference |
| 11/24/2011 | US20110289608 Antisense modulation of interleukins 17 and 23 signaling |
| 11/24/2011 | US20110289607 Method of inhibiting gene expression |
| 11/24/2011 | US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease |
| 11/24/2011 | US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof |
| 11/24/2011 | US20110288472 Bladder cancer treatment and methods |
| 11/24/2011 | US20110288363 Biologically Enhanced Irrigants |
| 11/24/2011 | US20110288238 Enhanced transport using membrane disruptive agents |
| 11/24/2011 | US20110288180 Dietary purgatives |
| 11/24/2011 | US20110288179 Bimatoprost crystalline form i |
| 11/24/2011 | US20110288178 Radioprotective agents |
| 11/24/2011 | US20110288177 Methods for Preventing or Reducing Colon Carcinogenesis |
| 11/24/2011 | US20110288176 Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same |
| 11/24/2011 | US20110288175 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 11/24/2011 | US20110288174 Monohydrate of 4-(phenyl)ethyl]-amino}methyl)benzoic acid |
| 11/24/2011 | US20110288173 Use of neboglamine in the treatment of toxicodependency |
| 11/24/2011 | US20110288172 Dermatological compositions and methods |
| 11/24/2011 | US20110288171 Methods of treating hypertriglyceridemia |
| 11/24/2011 | US20110288170 Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| 11/24/2011 | US20110288169 Triterpenoid compounds and methods of use thereof |
| 11/24/2011 | US20110288168 Histone deacetylase inhibitors |